ArticlePloS one2025

Cancer related adverse events associated with use of proton pump inhibitors and histamine-2 receptor antagonists: A real-world analysis using the FDA adverse event reporting system.

Bowen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.